A study led by the Gwangju Institute of Science and Technology (GIST) developed the new defect passivation strategy. The ...
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...
Researchers have developed a novel passivation process for formamidinium lead iodide perovskite films, which reportedly ...
The U.S.-based drugmaker also plans to provide the companies branded version of the drug, lenacapavir, in 18 countries, such ...
Gilead Sciences is wasting no time in promoting worldwide access to its twice-yearly pre-exposure prophylaxis (PrEP) HIV ...
With women, as Étienne had somehow sensed, I’m a very attentive, confident, and giving top. My pleasure comes mostly from ...
Dr Reddy's Laboratories and Hetero, along with other generic drug makers, enter into voluntary licensing agreements with ...
Pharmaceutical firm Hetero has partnered with Gilead Sciences Ireland UC to manufacture and distribute the HIV treatment drug lenacapavir in 120 primarily low- and lower-middle-income countries. The ...
Many of us are worried about loneliness and isolation, and both decade-old and recent data suggest they impact men more than ...
A decade of data shows Australian men appear to focus their emotional energies primarily on their nuclear families and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback